TNON Key Statistics, Chart & Performance
The current stock price of TNON is 1.12 USD. In the past month the price decreased by -3.42%. In the past year, price decreased by -48.17%.
TNON Latest News, Press Relases and Analysis
TNON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.87 | 215.80B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.69 | 200.49B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.17 | 145.06B | ||
| SYK | STRYKER CORP | 27.64 | 139.20B | ||
| IDXX | IDEXX LABORATORIES INC | 56.89 | 57.28B | ||
| BDX | BECTON DICKINSON AND CO | 13.39 | 55.33B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.14 | 49.43B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.97 | 37.58B | ||
| RMD | RESMED INC | 25.45 | 36.78B | ||
| DXCM | DEXCOM INC | 34.54 | 25.06B | ||
| PODD | INSULET CORP | 68.2 | 21.93B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.42 | 18.30B |
Related stock screener links
About TNON
Company Profile
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 27 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.
Company Info
TENON MEDICAL INC
104 Cooper Ct.
Los Gatos CALIFORNIA US
Employees: 27
Phone: 14086495760
TENON MEDICAL INC / TNON FAQ
What does TNON do?
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 27 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.
What is the stock price of TENON MEDICAL INC today?
The current stock price of TNON is 1.12 USD. The price decreased by -0.88% in the last trading session.
What is the dividend status of TENON MEDICAL INC?
TNON does not pay a dividend.
What is the ChartMill rating of TENON MEDICAL INC stock?
TNON has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of TENON MEDICAL INC (TNON)?
TENON MEDICAL INC (TNON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.31).
Is TENON MEDICAL INC (TNON) expected to grow?
The Revenue of TENON MEDICAL INC (TNON) is expected to grow by 2.22% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for TNON stock?
TENON MEDICAL INC (TNON) will report earnings on 2026-03-18, after the market close.
TNON Technical Analysis
TNON Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TNON. TNON scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
TNON Financial Highlights
Over the last trailing twelve months TNON reported a non-GAAP Earnings per Share(EPS) of -4.31. The EPS increased by 84.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -113.84% | ||
| ROE | -188.47% | ||
| Debt/Equity | 0 |
TNON Forecast & Estimates
8 analysts have analysed TNON and the average price target is 2.81 USD. This implies a price increase of 150.45% is expected in the next year compared to the current price of 1.12.
For the next year, analysts expect an EPS growth of 92.89% and a revenue growth 2.22% for TNON